Legal & General Group
BIOA

Legal & General Group’s BioAge Labs BIOA Stock Holding History

Legal & General Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.7K Buy
3,413
+758
+29% +$13.7K ﹤0.01% 2659
2026
Q1 		$46.4K Buy
2,655
+503
+23% +$9.69K ﹤0.01% 2690
2025
Q4 		$28.5K Hold
2,152
– – ﹤0.01% 2891
2025
Q3 		$12.7K Hold
2,152
– – ﹤0.01% 3225
2025
Q2 		$8.89K Buy
2,152
+832
+63% +$3.35K ﹤0.01% 3321
2025
Q1 		$4.96K Hold
1,320
– – ﹤0.01% 3280
2024
Q4 		$7.69K Buy
+1,320
New +$22.8K ﹤0.01% 3298

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Legal & General Group's BIOA Position: Q2 2026 in Review

Legal & General Group increased its BioAge Labs (BIOA) stake by 29% in Q2 2026, buying an estimated $13.7K and bringing the position to 3,413 shares worth $83.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2659.

Legal & General Group first reported a position in BIOA in Q4 2024 and has held it in 7 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Legal & General Group held 3,413 shares of BioAge Labs worth $83.7K as of Q2 2026.
  • Legal & General Group bought 758 BioAge Labs shares in Q2 2026, an estimated $13.7K.
  • BioAge Labs made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2659 holding.
  • Legal & General Group first reported a position in BioAge Labs in Q4 2024 and has held it in 7 quarters since.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.